Astera Labs, Inc. (NASDAQ:ALAB) Stock Has Average Target Price of $340.79 According to Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus rating of “Moderate Buy” from the twenty-two research firms that are covering the stock, MarketBeat.com reports. Eleven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $340.79.

ALAB has been the topic of several research analyst reports. Weiss Ratings downgraded Astera Labs from a “buy (b-)” rating to a “hold (c)” rating in a research note on Friday, October 23rd. Roth Capital reaffirmed a “buy” rating and set a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Susquehanna increased their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Jefferies Financial Group boosted their price target on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, Citigroup downgraded Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th.

Astera Labs Stock Performance

ALAB opened at $290.43 on Tuesday. The stock has a market cap of $50.39 billion, a price-to-earnings ratio of 143.78 and a beta of 3.68. Astera Labs has a one year low of $97.89 and a one year high of $499.48. The stock’s 50 day moving average price is $308.75 and its 200-day moving average price is $254.55.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the firm earned $0.44 EPS. The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts predict that Astera Labs will post 2.71 earnings per share for the current fiscal year.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the firm’s stock in a transaction dated Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the completion of the transaction, the director directly owned 2,648 shares in the company, valued at approximately $995,806.88. This represents a 77.25% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. BOCHK Asset Management Ltd grew its stake in shares of Astera Labs by 192.7% in the 3rd quarter. BOCHK Asset Management Ltd now owns 20,050 shares of the company’s stock valued at $7,137,000 after buying an additional 13,200 shares during the period. Signature Equity Partners LLC raised its stake in shares of Astera Labs by 1,680.0% in the third quarter. Signature Equity Partners LLC now owns 89 shares of the company’s stock valued at $32,000 after acquiring an additional 84 shares in the last quarter. Summit Wealth Group LLC Co. purchased a new position in Astera Labs in the third quarter worth approximately $250,000. Bank Julius Baer & Co. Ltd Zurich boosted its holdings in Astera Labs by 101.4% in the third quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,734 shares of the company’s stock valued at $1,330,000 after purchasing an additional 1,880 shares in the last quarter. Finally, Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Astera Labs by 6.0% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 342,169 shares of the company’s stock worth $121,802,000 after purchasing an additional 19,250 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.